Days Inventory is also known as Days Sales of Inventory (DSI). Affymetrix's Average Total Inventories for the
three
months ended in Dec. 2015 was $53.8 Mil. Affymetrix's Cost of Goods Sold for the
three
months ended in Dec. 2015 was $33.8 Mil.
Hence, Affymetrix's Days Inventory for the
three
months ended in Dec. 2015 was 145.31.
The historical rank and industry rank for Affymetrix's Days Inventory or its related term are showing as below:
AFFX's Days Inventory is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 65.4 * Ranked among companies with meaningful Days Inventory only.
Affymetrix's Days Inventory
increased
from Dec. 2014 (135.01) to Dec. 2015 (145.31).
It might indicate that Affymetrix's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Affymetrix's Inventory Turnover for the
three
months ended in Dec. 2015 was 0.63.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Affymetrix's Inventory-to-Revenue for the
three
months ended in Dec. 2015 was 0.56.
Affymetrix Days Inventory Historical Data
The historical data trend for Affymetrix's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Affymetrix's Days Inventory
For the Diagnostics & Research subindustry, Affymetrix's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Affymetrix's Days Inventory Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Affymetrix's Days Inventory distribution charts can be found below:
* The bar in red indicates where Affymetrix's Days Inventory falls into.
Affymetrix Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Affymetrix's Days Inventory for the fiscal year that ended in Dec. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Affymetrix (NAS:AFFX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Affymetrix's Inventory Turnover for the
three
months ended in Dec. 2015 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Affymetrix's Inventory to Revenue for the
three
months ended in Dec. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Affymetrix Days Inventory Related Terms
Thank you for viewing the detailed overview of Affymetrix's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Affymetrix Inc was incorporated in California in 1992 and reincorporated in Delaware in 1998. The Company is a provider of life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. It sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. The Companys operations consist of two reportable segments, Affymetrix Core and eBioscience. Affymetrix Core is divided into three business units with each business unit having its own research, development and marketing groups to better serve customers and respond quickly to the market needs. The three business units that form Affymetrix Core are; Expression, Genetic Analysis and Clinical Applications, and Life Science Reagents. Expression: This business unit develops and markets the Company's GeneChip gene expression products and services, and the QuantiGene line of low-to-mid-plex RNA measurement products; Genetic Analysis and Clinical Applications. This business unit develops and markets the Company's genotyping, such as the Axiom product line and clinical research applications, such as the CytoScan cytogenetics; Life Science Reagents; This business unit develops and sells reagents, enzymes, purification kits and biochemicals used by life science researchers. eBioscience; This reportable segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company markets and distributes its products directly to customers in North America, Japan and major European markets. The Company is facing competition as existing companies develop new or improved products, and as companies enter the market with new technologies, such as next-generation sequencing. In the highly multiplexed genotyping and gene expression markets, existing competitive technologies include DNA sequencing, which the Company does not offer and is offered by companies such as Illumina, Inc., Life Technologies Corporation and Pacific Biosciences of California, Inc. The Companys operations are subject to complex and stringent environmental, health, safety and other governmental laws and regulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AFFX has been successfully added to your 